Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox in schizophrenia
NCT00366327Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bifeprunox in schizophrenia, sponsored by Pfizer. Started Jan 2007; status: terminated.
02
Drugs
bifeprunox
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00366327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366327.